Home
Conditions
Refractory Acute Myeloid Leukemia

Clinical trial condition

Refractory Acute Myeloid Leukemia

Explore clinical trials studying Refractory Acute Myeloid Leukemia. Study availability and eligibility vary by location and protocol.

100 public trials 42 recruiting studies

Refine in advanced search Browse all conditions

Refractory Acute Myeloid Leukemia trial results

Recruiting

CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia

NCT05672147

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Recruiting

Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia

NCT03214562

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, High Risk Myelodysplastic Syndrome, +7 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation

NCT03683433

Conditions: Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Bone Marrow Diseases, +25 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

NCT04375631

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +27 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Recruiting

Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy

NCT03630991

Conditions: Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Blast Crisis, +35 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Venetoclax and Bomedemstat in Patients With Relapsed/Refractory Acute Myeloid Leukemia

NCT05597306

Conditions: Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse, Hematologic Diseases, +7 more
Locations: University of Miami Miami, Florida, United States

View Trial Details

Recruiting

Clinical Study of LILRA6 CAR-T for the Treatment of R/R Acute Myeloid Leukemia

NCT07263906

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +6 more
Locations: The Second Affiliated Hospital,School of Medicine,Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Recruiting

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

NCT06501196

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: City of Hope Medical Center Duarte, California, United States

University of California Los Angeles Los Angeles, California, United States

Stanford Cancer Center Palo Alto, California, United States

Sylvester Comprehensive Cancer Center Miami, Florida, United States

View all 13 locations

View Trial Details

Recruiting

Clinical Trial of WBC100 Capsule in Relapsed/Refractory Acute Myeloid Leukemia

NCT07014449

Conditions: AML (Acute Myelogenous Leukemia, Adult Acute Myeloid Leukemia, C-Myc, +16 more
Locations: The First Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Safety and Efficacy of Mitoxantrone Hydrochloride Liposome Based DCMG Regimen for R/R AML

NCT06741722

Conditions: AML, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations: Chinese PLA General Hospital Beijing, China

View Trial Details

Refractory Acute Myeloid Leukemia

Refractory Acute Myeloid Leukemia trial results

Related conditions